CRANE CO (CR)

US2244081046 - Common Stock

153.37  -0.57 (-0.37%)

Fundamental Rating

5

Taking everything into account, CR scores 5 out of 10 in our fundamental rating. CR was compared to 131 industry peers in the Machinery industry. Both the health and profitability get an excellent rating, making CR a very profitable company, without any liquidiy or solvency issues. CR is valied quite expensively at the moment, while it does show a decent growth rate.



7

1. Profitability

1.1 Basic Checks

In the past year CR was profitable.
In the past year CR had a positive cash flow from operations.
CR had positive earnings in each of the past 5 years.
CR had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

With an excellent Return On Assets value of 9.92%, CR belongs to the best of the industry, outperforming 80.62% of the companies in the same industry.
With a decent Return On Equity value of 16.71%, CR is doing good in the industry, outperforming 75.19% of the companies in the same industry.
CR has a better Return On Invested Capital (11.54%) than 75.19% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CR is below the industry average of 11.22%.
The 3 year average ROIC (7.54%) for CR is below the current ROIC(11.54%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.92%
ROE 16.71%
ROIC 11.54%
ROA(3y)12.5%
ROA(5y)8.89%
ROE(3y)26.74%
ROE(5y)20.22%
ROIC(3y)7.54%
ROIC(5y)7.39%

1.3 Margins

CR's Profit Margin of 11.56% is fine compared to the rest of the industry. CR outperforms 79.07% of its industry peers.
CR's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 15.73%, CR is in the better half of the industry, outperforming 77.52% of the companies in the same industry.
In the last couple of years the Operating Margin of CR has remained more or less at the same level.
CR's Gross Margin of 38.49% is fine compared to the rest of the industry. CR outperforms 71.32% of its industry peers.
CR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 15.73%
PM (TTM) 11.56%
GM 38.49%
OM growth 3Y9.04%
OM growth 5Y-0.57%
PM growth 3Y25.78%
PM growth 5Y4.1%
GM growth 3Y4.04%
GM growth 5Y1.65%

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CR is creating some value.
Compared to 1 year ago, CR has more shares outstanding
The number of shares outstanding for CR has been reduced compared to 5 years ago.
The debt/assets ratio for CR is higher compared to a year ago.

2.2 Solvency

CR has an Altman-Z score of 7.12. This indicates that CR is financially healthy and has little risk of bankruptcy at the moment.
CR has a Altman-Z score of 7.12. This is amongst the best in the industry. CR outperforms 86.05% of its industry peers.
The Debt to FCF ratio of CR is 1.79, which is an excellent value as it means it would take CR, only 1.79 years of fcf income to pay off all of its debts.
CR has a Debt to FCF ratio of 1.79. This is amongst the best in the industry. CR outperforms 84.50% of its industry peers.
A Debt/Equity ratio of 0.21 indicates that CR is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.21, CR is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 1.79
Altman-Z 7.12
ROIC/WACC1.21
WACC9.51%

2.3 Liquidity

CR has a Current Ratio of 2.18. This indicates that CR is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 2.18, CR perfoms like the industry average, outperforming 53.49% of the companies in the same industry.
CR has a Quick Ratio of 1.48. This is a normal value and indicates that CR is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.48, CR is doing good in the industry, outperforming 63.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.18
Quick Ratio 1.48

4

3. Growth

3.1 Past

The earnings per share for CR have decreased strongly by -12.89% in the last year.
Measured over the past years, CR shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.47% on average per year.
The Revenue has grown by 11.63% in the past year. This is quite good.
Measured over the past years, CR shows a decrease in Revenue. The Revenue has been decreasing by -9.01% on average per year.
EPS 1Y (TTM)-12.89%
EPS 3Y3.68%
EPS 5Y-6.47%
EPS Q2Q%33.98%
Revenue 1Y (TTM)11.63%
Revenue growth 3Y-10.77%
Revenue growth 5Y-9.01%
Sales Q2Q%12.66%

3.2 Future

Based on estimates for the next years, CR will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.57% on average per year.
The Revenue is expected to grow by 6.85% on average over the next years.
EPS Next Y22.82%
EPS Next 2Y17.4%
EPS Next 3Y15.4%
EPS Next 5Y13.57%
Revenue Next Year9.55%
Revenue Next 2Y7.86%
Revenue Next 3Y6.77%
Revenue Next 5Y6.85%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 31.95, the valuation of CR can be described as expensive.
Based on the Price/Earnings ratio, CR is valued a bit more expensive than the industry average as 64.34% of the companies are valued more cheaply.
CR is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.35, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 26.00, which means the current valuation is very expensive for CR.
Based on the Price/Forward Earnings ratio, CR is valued a bit more expensive than the industry average as 61.24% of the companies are valued more cheaply.
When comparing the Price/Forward Earnings ratio of CR to the average of the S&P500 Index (23.86), we can say CR is valued inline with the index average.
Industry RankSector Rank
PE 31.95
Fwd PE 26

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CR indicates a slightly more expensive valuation: CR is more expensive than 65.12% of the companies listed in the same industry.
CR's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 47.45
EV/EBITDA 21.51

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CR has a very decent profitability rating, which may justify a higher PE ratio.
CR's earnings are expected to grow with 15.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.4
PEG (5Y)N/A
EPS Next 2Y17.4%
EPS Next 3Y15.4%

4

5. Dividend

5.1 Amount

With a yearly dividend of 0.52%, CR is not a good candidate for dividend investing.
CR's Dividend Yield is comparable with the industry average which is at 1.67.
With a Dividend Yield of 0.52, CR pays less dividend than the S&P500 average, which is at 2.30.
Industry RankSector Rank
Dividend Yield 0.52%

5.2 History

On average, the dividend of CR grows each year by 51.53%, which is quite nice.
CR has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)51.53%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

CR pays out 17.26% of its income as dividend. This is a sustainable payout ratio.
CR's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP17.26%
EPS Next 2Y17.4%
EPS Next 3Y15.4%

CRANE CO

NYSE:CR (12/30/2024, 12:11:26 PM)

153.37

-0.57 (-0.37%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)10-28 2024-10-28/amc
Earnings (Next)N/A N/A
Inst Owners74.79%
Inst Owner Change-44.02%
Ins Owners0.25%
Ins Owner Change0%
Market Cap8.78B
Analysts82.5
Price Target185.49 (20.94%)
Short Float %1.66%
Short Ratio3.17
Dividend
Industry RankSector Rank
Dividend Yield 0.52%
Dividend Growth(5Y)51.53%
DP17.26%
Div Incr Years0
Div Non Decr Years0
Ex-Date11-29 2024-11-29 (0.205)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.66%
Min EPS beat(2)1.58%
Max EPS beat(2)1.75%
EPS beat(4)4
Avg EPS beat(4)3.64%
Min EPS beat(4)1.58%
Max EPS beat(4)6%
EPS beat(8)8
Avg EPS beat(8)12.11%
EPS beat(12)11
Avg EPS beat(12)9.07%
EPS beat(16)14
Avg EPS beat(16)11.55%
Revenue beat(2)0
Avg Revenue beat(2)-1.59%
Min Revenue beat(2)-2.46%
Max Revenue beat(2)-0.71%
Revenue beat(4)1
Avg Revenue beat(4)-0.83%
Min Revenue beat(4)-2.46%
Max Revenue beat(4)0.45%
Revenue beat(8)3
Avg Revenue beat(8)-5.72%
Revenue beat(12)5
Avg Revenue beat(12)0.35%
Revenue beat(16)8
Avg Revenue beat(16)1.24%
PT rev (1m)1.76%
PT rev (3m)7.34%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.24%
EPS NY rev (1m)-1.02%
EPS NY rev (3m)-42.1%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.04%
Revenue NY rev (1m)-2.54%
Revenue NY rev (3m)-37.53%
Valuation
Industry RankSector Rank
PE 31.95
Fwd PE 26
P/S 3.86
P/FCF 47.45
P/OCF 39.27
P/B 5.58
P/tB 14.78
EV/EBITDA 21.51
EPS(TTM)4.8
EY3.13%
EPS(NY)5.9
Fwd EY3.85%
FCF(TTM)3.23
FCFY2.11%
OCF(TTM)3.91
OCFY2.55%
SpS39.78
BVpS27.51
TBVpS10.38
PEG (NY)1.4
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.92%
ROE 16.71%
ROCE 17.22%
ROIC 11.54%
ROICexc 13.11%
ROICexgc 26.98%
OM 15.73%
PM (TTM) 11.56%
GM 38.49%
FCFM 8.13%
ROA(3y)12.5%
ROA(5y)8.89%
ROE(3y)26.74%
ROE(5y)20.22%
ROIC(3y)7.54%
ROIC(5y)7.39%
ROICexc(3y)9.11%
ROICexc(5y)8.73%
ROICexgc(3y)17.98%
ROICexgc(5y)19.31%
ROCE(3y)11.08%
ROCE(5y)11.03%
ROICexcg growth 3Y17.27%
ROICexcg growth 5Y-1.49%
ROICexc growth 3Y26.24%
ROICexc growth 5Y3.13%
OM growth 3Y9.04%
OM growth 5Y-0.57%
PM growth 3Y25.78%
PM growth 5Y4.1%
GM growth 3Y4.04%
GM growth 5Y1.65%
F-Score3
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 1.79
Debt/EBITDA 0.81
Cap/Depr 75.64%
Cap/Sales 1.69%
Interest Coverage 250
Cash Conversion 54.65%
Profit Quality 70.32%
Current Ratio 2.18
Quick Ratio 1.48
Altman-Z 7.12
F-Score3
WACC9.51%
ROIC/WACC1.21
Cap/Depr(3y)98.17%
Cap/Depr(5y)76.37%
Cap/Sales(3y)1.86%
Cap/Sales(5y)1.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.89%
EPS 3Y3.68%
EPS 5Y-6.47%
EPS Q2Q%33.98%
EPS Next Y22.82%
EPS Next 2Y17.4%
EPS Next 3Y15.4%
EPS Next 5Y13.57%
Revenue 1Y (TTM)11.63%
Revenue growth 3Y-10.77%
Revenue growth 5Y-9.01%
Sales Q2Q%12.66%
Revenue Next Year9.55%
Revenue Next 2Y7.86%
Revenue Next 3Y6.77%
Revenue Next 5Y6.85%
EBIT growth 1Y29.14%
EBIT growth 3Y-2.7%
EBIT growth 5Y-9.53%
EBIT Next Year40.97%
EBIT Next 3Y20.68%
EBIT Next 5Y14.3%
FCF growth 1Y124.34%
FCF growth 3Y-12.34%
FCF growth 5Y-9.47%
OCF growth 1Y130.81%
OCF growth 3Y-9.66%
OCF growth 5Y-11.22%